Pancreatic cancer is the ninth most commonly diagnosed cancer in the United States and the fourth leading cause of cancer death, claiming more than 35,000 lives each year. While smoking, alcohol abuse, and certain dietary factors have been linked to the disease, many people who receive a diagnosis have no identifiable risk factors. And because there is no early detection test for pancreatic cancer, it is usually quite advanced by the time it causes symptoms, making it difficult to treat successfully.
The NYU Cancer Institute is tackling the challenge of pancreatic cancer using a multidisciplinary team of basic science investigators and clinicians from a variety of fields (including surgery, medical and radiation oncology, gastroenterology, radiology, pathology, biochemistry, and cell biology).
Team members meet monthly to discuss their clinical and research findings, exchange information, and forge new collaborations aimed at deciphering the biology of the disease and optimizing treatment approaches. Investigations are truly translational, with laboratory researchers gleaning new insights into the disease that can be evaluated in the clinic, and clinicians identifying new avenues of research through experiences with their patients.
Our pancreatic cancer experts evaluate and treat patients in the state-of-the-art NYU Clinical Cancer Center, a collaborative, multidisciplinary clinic setting located on East 34th Street at Third Avenue. Patients can undergo diagnostic tests, learn the results of those tests, and receive a personalized treatment plan -- all under the same roof.
Whether you are seeking a second opinion or are ready to start treatment, we encourage you to see one of our specialists to learn about your diagnostic and treatment options and make an informed decision about your care.